C. Domenge

9.6k total citations · 3 hit papers
62 papers, 7.2k citations indexed

About

C. Domenge is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, C. Domenge has authored 62 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Otorhinolaryngology, 27 papers in Surgery and 26 papers in Oncology. Recurrent topics in C. Domenge's work include Head and Neck Cancer Studies (44 papers), Head and Neck Surgical Oncology (14 papers) and Salivary Gland Tumors Diagnosis and Treatment (11 papers). C. Domenge is often cited by papers focused on Head and Neck Cancer Studies (44 papers), Head and Neck Surgical Oncology (14 papers) and Salivary Gland Tumors Diagnosis and Treatment (11 papers). C. Domenge collaborates with scholars based in France, Belgium and United States. C. Domenge's co-authors include Jean Bourhis, Jean‐Pierre Pignon, M. Bolla, B Luboïnski, M. van Glabbeke, J. Giralt, Richard Greiner, F. Cognetti, Frédéric Rolland and Jacques Bernier and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

C. Domenge

60 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

2004 2.2k citations Jacques Bernier, C. Domenge et al. New England Journal of Medicine profile →
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

2000 1.9k citations Jean‐Pierre Pignon, Jean Bourhis et al. profile →
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer

2001 583 citations Jean‐Pierre Pignon, Jean Bourhis et al. profile →

Peers

Countries citing papers authored by C. Domenge

Since Specialization

Citations

This map shows the geographic impact of C. Domenge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Domenge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Domenge more than expected).

Fields of papers citing papers by C. Domenge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Domenge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Domenge. The network helps show where C. Domenge may publish in the future.

Co-authorship network of co-authors of C. Domenge

This figure shows the co-authorship network connecting the top 25 collaborators of C. Domenge. A scholar is included among the top collaborators of C. Domenge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Domenge. C. Domenge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial 2011 ·Radiotherapy and Oncology ·Jean Bourhis, M. Lapeyre, J. Tortochaux, Antoine Lusinchi, (unknown), (unknown), L. Geoffrois, C. Domenge, Pierre Verrelle, P. Wibault, François Janot, Stéphane Temam, Pierre Blanchard, Yungan Tao, Anne Aupérin	18
2	Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck 2005 ·Head & Neck ·Sandrine Faivre, (unknown), Olivier Rixe, François Janot, M. Juliéron, Michel Gatineau, Stéphane Temam, Jean‐Pierre Armand, C. Domenge, B Luboïnski, Éric Raymond	3
3	Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer breakdown → 2004 ·New England Journal of Medicine ·Jacques Bernier, C. Domenge, Mahmut Özsahin, Katarzyna Łukawska‐Matuszewska, Jean-Louis Lefèbvre, Richard Greiner, J. Giralt, P. Maingon, Frédéric Rolland, M. Bolla, F. Cognetti, Jean Bourhis, Anne Kirkpatrick, M. van Glabbeke	2209
4	Locoregional effects of pegylated liposomal doxorubicin (Caelyx®) in irradiated area: a phase I–II study in patients with recurrent squamous cell carcinoma of the head and neck 2004 ·European Journal of Cancer ·Sandrine Faivre, (unknown), (unknown), François Janot, M. Juliéron, C. Domenge, (unknown), Jean‐Pierre Armand, B Luboïnski, Éric Raymond	9
5	Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck 2004 ·Anti-Cancer Drugs ·Jean‐Pierre Pignon, Nathalie Syz, Marshall R. Posner, Robert Olivares, (unknown), Antoine Yver, Ariane Dunant, Freddi Lewin, D. Dalley, Adriano Paccagnella, Samuel G. Taylor, C. Domenge, Jean Bourhis, Madhu Mazumdar	52
6	Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx 2001 ·Leukemia ·Vincent Ribrag, (unknown), François Janot, T. Girinsky, C. Domenge, G Schwaab, Pierre Fenaux, J. Bosq	77
7	Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy 1998 ·British Journal of Cancer ·LM Mir, (unknown), Gregor Serša, Justin Teissié, C. Domenge, Damijan Miklavčič, (unknown), Stéphane Orlowski, Reintgen Ds, Z Rudolf, (unknown), R. A. Gilbert, Marie‐Pierre Rols, Jean Belehradek, J.M. Bachaud, Ronald C. DeConti, Borut Štabuc, Maja Čemažar, P Coninx, Richard Heller	356
8	Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. 1998 ·Journal of Clinical Oncology ·R. de Crevoisier, Jean Bourhis, C. Domenge, P. Wibault, Serge Koscielny, A. Lusinchi, G Mamelle, François Janot, M. Juliéron, A. M. Leridant, P Marandas, P. Armand, G Schwaab, B Luboïnski, F. Eschwège	260
9	Combined transfacial and neurosurgical approach to malignant tumours of the ethmoid sinus 1998 ·The Journal of Laryngology & Otology ·Didier Salvan, M. Juliéron, P Marandas, François Janot, A. M. Leridant, C. Domenge, G. Mamelle, G Schwaab, B Luboïnski	30
10	[Isolated mandibular metastases. Therapeutic strategy. Apropos of 7 cases]. 1997 ·PubMed ·(unknown), P Marandas, (unknown), M. Juliéron, M. Schlumberger, G Mamelle, C. Domenge	1
11	Antitumor electrochemotherapy: New advances in the clinical protocol 1996 ·Cancer ·C. Domenge, (unknown), B Luboïnski, Thierry de Baère, G Schwaab, (unknown), Lluis M. Mir	149
12	Very accelerated radiation therapy: Preliminary results in locally unresectable head and neck carcinomas 1995 ·International Journal of Radiation OncologyBiologyPhysics ·Jean Bourhis, (unknown), Olivier Dupuis, C. Domenge, Antoine Lusinchi, (unknown), G Schwaab, Jean Pierre Armand, B Luboïnski, Edmond P. Malaise, François Eschwège, (unknown)	31
13	[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination]. 1995 ·PubMed ·P Cappelaere, B Hecquet, F. Rolland, (unknown), C. Domenge, I. Krakowski, (unknown), J Chauvergne, (unknown), Patrice Carde	3
14	Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients 1993 ·European Journal of Cancer ·M Forni, Jean‐Pierre Armand, Xavier Fontana, Gonzálo Recondo, C. Domenge, Patrice Carde, G G Chabot, Alain Gouyette, (unknown)	14
15	Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial 1993 ·Cancer ·(unknown), C. Domenge, B Luboïnski, Stéphane Orlowski, Jean Belehradek, Lluis M. Mir	371
16	Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (MO) disease 1991 ·Cancer ·Gonzálo Recondo, Esteban Cvitkovic, N. Azli, (unknown), Florent de Vathaire, (unknown), J Richard, (unknown), Mohamed Benahmed, C. Domenge, F Eschwège, (unknown)	16
17	Recurrent and/or metastatic head and neck squamous cell carcinoma: A clinical, univariate and multivariate analysis of response and survival with cisplatin‐based chemotherapy 1991 ·The Laryngoscope ·Gonzálo Recondo, Jean‐Pierre Armand, (unknown), Esteban Cvitkovic, (unknown), C. Domenge, (unknown), Florent de Vathaire, P. Wibault	32
18	A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer 1990 ·Cancer ·(unknown), Gonzálo Recondo, Thierry Guillot, (unknown), C. Domenge, Julie Izzo, Esteban Cvitkovic, Jean Pierre Armand	3
19	Phase II study of mitozolomide (M & B 39,565) in head and neck cancer 1989 ·Medical Oncology and Tumor Pharmacotherapy ·Patrice Herait, Jean‐Pierre Armand, Mohamed Benahmed, C. Domenge, Xavier Fontana, Gonzalo Recondo, Esteban Cvitkovic, F.M. Delgado	2
20	Olfactory esthesioneuroma: A report of 40 cases 1988 ·The Laryngoscope ·G Schwaab, (unknown), P Marandas, C. Le Guillou, J Richard, C Micheau, P. Wibault, C. Domenge	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact